Medite Cancer Diagnostics Insider Trades

MDIT

Track insider trading activity from Medite Cancer Diagnostics executives and directors. See which insiders are buying and selling MDIT stock.

Trades Last 12 Months

All Insider Trades for Medite Cancer Diagnostics

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $3.66k 36,611,163 shares
Last Trade
Oct 15, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Abeles John H Director
Holding Value $157 1,566,852 shares
Last Trade
Oct 11, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Holding Value $26.7 266,666 shares
Last Trade
Jul 27, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Holding Value $153 1,533,334 shares
Last Trade
Apr 04, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Kanter Joel S Director
Holding Value $0 0 shares
Last Trade
Mar 27, 2018 Sale
No data
No data
$0.00
Ott Michaela 10% owner, Chief Executive Officer
Holding Value $750 7,500,000 shares
Last Trade
Oct 05, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Ott Michael Egbert 10% owner, President And COO
Holding Value $750 7,500,000 shares
Last Trade
Oct 05, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Mccullogh Robert F Jr 10% owner, CEO And CFO
Holding Value $16.8k 167,524,501 shares
Last Trade
May 20, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up